We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+12.36%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$525M
AUM Growth
+$163M
Cap. Flow
-$365M
Cap. Flow %
-69.47%
Top 10 Hldgs %
34.54%
Holding
251
New
–
Increased
–
Reduced
–
Closed
140

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$17.3M
2
GIS icon
General Mills
GIS
+$16.1M
3
HGV icon
Hilton Grand Vacations
HGV
+$13.9M
4
D icon
Dominion Energy
D
+$13.5M
5
ACGL icon
Arch Capital
ACGL
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 20.2%
2 Financials 16.74%
3 Technology 15.78%
4 Industrials 10.99%
5 Energy 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DNTH icon
76
Dianthus Therapeutics
DNTH
$6.09B
– –
0
– –
SEND
77
DELISTED
SendGrid, Inc.
SEND
– –
0
– –
CBUS icon
78
Cibus
CBUS
$138M
– –
0
– –
BERY
79
DELISTED
Berry Global Group, Inc.
BERY
– –
-43,560
Closed -$2.02M
TCDA
80
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
0
– –
UXIN
81
Uxin Ltd
UXIN
$282M
– –
0
– –
NAAS
82
NaaS Technology Inc
NAAS
$59.1M
– –
0
– –
VTIQU
83
DELISTED
VectoIQ Acquisition Corp. Unit
VTIQU
– –
0
– –
ATTO
84
DELISTED
Atento S.A.
ATTO
– –
-13,250
Closed -$504K
MB
85
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
– –
0
– –
KZR
86
DELISTED
Kezar Life Sciences
KZR
– –
0
– –
CVLT icon
87
Commault Systems
CVLT
$5.61B
– –
0
– –
LOGM
88
DELISTED
LogMein, Inc.
LOGM
– –
-17,500
Closed -$1.96M
TBIO
89
DELISTED
Translate Bio, Inc. Common Stock
TBIO
– –
0
– –
NTGN
90
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
– –
0
– –
DCH
91
Dauch Corp
DCH
$1.51B
– –
-100,000
Closed -$1.61M
OBSV
92
DELISTED
ObsEva SA Ordinary Shares
OBSV
– –
0
– –
VKTX icon
93
Viking Therapeutics
VKTX
$4B
– –
0
– –
ARDX icon
94
Ardelyx
ARDX
$997M
– –
0
– –
MDGL icon
95
Madrigal Pharmaceuticals
MDGL
$11.8B
– –
0
– –
ASUR icon
96
Asure Software
ASUR
$250M
– –
0
– –
TTOO
97
DELISTED
T2 Biosystems, Inc
TTOO
– –
-4
Closed -$152K
MYE icon
98
Myers Industries
MYE
$1.29B
– –
0
– –
BL icon
99
BlackLine
BL
$1.72B
– –
0
– –
IIIV icon
100
i3 Verticals
IIIV
$342M
– –
0
– –
2 3
4
5 6

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Monashee Investment Management held 251 positions worth $525M, up 45% from $362M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Monashee Investment Management withdrew a net $365M in Q2 2018, closing 140 positions. Its most notable exit was Sage Therapeutics, an estimated $17.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Financials and Technology.

  • Monashee Investment Management fully exited Sage Therapeutics in Q2 2018, selling an estimated $17.3M.
  • Monashee Investment Management's ten largest holdings make up 35% of its $525M portfolio in Q2 2018.
  • Monashee Investment Management opened 0 new positions and closed 140 in Q2 2018.
  • Monashee Investment Management's portfolio value rose 45% quarter-over-quarter to $525M.

Based on Monashee Investment Management's 13F filing for Q2 2018, filed 10 Aug 2018.